skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Gemcitabine-Cisplatin Regimen (Code C63406)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Gemcitabine-Cisplatin Regimen

Definition: A chemotherapy regimen consisting of gemcitabine hydrochloride and cisplatin used in the treatment of advanced-stage non-small cell lung, advanced-stage bladder, advanced-stage cervical, pancreatic, and epithelial ovarian cancers; this regimen is also used in the treatment of malignant mesothelioma.

NCI-GLOSS Definition: A chemotherapy combination used to treat malignant mesothelioma, advanced non-small cell lung cancer, advanced bladder cancer, advanced cervical cancer, pancreatic cancer, and epithelial ovarian cancer. It is also being studied in the treatment of other types of cancer. It includes the drugs gemcitabine hydrochloride and cisplatin.

Label: Gemcitabine-Cisplatin Regimen

NCI Thesaurus Code: C63406 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1880939  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Gemcitabine-Cisplatin Regimen
gemcitabine/cisplatin regimen

External Source Codes: 
PDQ Closed Trial Search ID 631940
PDQ Open Trial Search ID 631940 (check for NCI PDQ open clinical trial info)
UMLS CUI C1880939

Other Properties:
     Name Value (qualifiers indented underneath)
code C63406
DesignNote Source: NCCN Guidelines 2007 (Non-Small Cell Lung, Pancreatic and Cervical)
DesignNote Source: NCCN Guidelines 2007 and PDQ
DesignNote Source: Physician's Cancer Chemotherapy Drug Manual 2006 (Ovarian)
Legacy_Concept_Name Gemcitabine-Cisplatin_Regimen
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom